NCT06117306: MDMA-assisted Massed Prolonged Exposure for PTSD
- State
- Under way
- Phase
- Phase 3
- People
- 20 planned
- Started
- 25 Oct 2024
- Primary completion
- Mar 2027
- Arms
- Dose A (exact dose not disclosed), Dose B (exact dose not disclosed)
- Results
- None posted
- 7 Nov 2023: Trial registered
- 25 Oct 2024: Trial started